| 000 | 01153 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513221439.0 | ||
| 264 | 0 | _c20001012 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0954-6111 | ||
| 024 | 7 |
_a10.1053/rmed.2000.0831 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdwards, A M | |
| 245 | 0 | 0 |
_aAssessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998. Snell NJC, Ganderton D. eds. Respir Med 1999; 93: 123-133. _h[electronic resource] |
| 260 |
_bRespiratory medicine _cSep 2000 |
||
| 300 |
_a918-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCromolyn Sodium _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLung |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aParticle Size |
| 773 | 0 |
_tRespiratory medicine _gvol. 94 _gno. 9 _gp. 918-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/rmed.2000.0831 _zAvailable from publisher's website |
| 999 |
_c10947272 _d10947272 |
||